Azad Engineering Ltd: Intrinsic Value & Share Price Analysis

Last Updated: March 25, 2026, 3:11 am

All Competitor Stocks of Azad Engineering Ltd

Last Updated: March 3, 2026, 12:00 pm

Below is a detailed analysis of the quarterly data for Azad Engineering Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:

• For Sales, as of Dec 2025, the value is 156.00 Cr.. The value appears strong and on an upward trend. It has increased from 143.00 Cr. (Sep 2025) to 156.00 Cr., marking an increase of 13.00 Cr..
• For Expenses, as of Dec 2025, the value is 96.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 91.00 Cr. (Sep 2025) to 96.00 Cr., marking an increase of 5.00 Cr..
• For Operating Profit, as of Dec 2025, the value is 60.00 Cr.. The value appears strong and on an upward trend. It has increased from 51.00 Cr. (Sep 2025) to 60.00 Cr., marking an increase of 9.00 Cr..
• For OPM %, as of Dec 2025, the value is 39.00%. The value appears strong and on an upward trend. It has increased from 36.00% (Sep 2025) to 39.00%, marking an increase of 3.00%.
• For Other Income, as of Dec 2025, the value is 9.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Sep 2025) to 9.00 Cr., marking a decrease of 4.00 Cr..
• For Interest, as of Dec 2025, the value is 8.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 6.00 Cr. (Sep 2025) to 8.00 Cr., marking an increase of 2.00 Cr..
• For Depreciation, as of Dec 2025, the value is 14.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 11.00 Cr. (Sep 2025) to 14.00 Cr., marking an increase of 3.00 Cr..
• For Profit before tax, as of Dec 2025, the value is 47.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 47.00 Cr..
• For Tax %, as of Dec 2025, the value is 28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 30.00% (Sep 2025) to 28.00%, marking a decrease of 2.00%.
• For Net Profit, as of Dec 2025, the value is 34.00 Cr.. The value appears strong and on an upward trend. It has increased from 33.00 Cr. (Sep 2025) to 34.00 Cr., marking an increase of 1.00 Cr..
• For EPS in Rs, as of Dec 2025, the value is 5.27. The value appears strong and on an upward trend. It has increased from 5.11 (Sep 2025) to 5.27, marking an increase of 0.16.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Last Updated: February 27, 2026, 12:00 am

Last Updated: September 5, 2025, 2:31 pm

Last Updated: December 4, 2025, 2:28 am

Below is a detailed analysis of the balance sheet data for Azad Engineering Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2025, the value is 13.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 13.00 Cr..
• For Reserves, as of Sep 2025, the value is 1,468.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,405.00 Cr. (Mar 2025) to 1,468.00 Cr., marking an increase of 63.00 Cr..
• For Borrowings, as of Sep 2025, the value is 300.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 252.00 Cr. (Mar 2025) to 300.00 Cr., marking an increase of 48.00 Cr..
• For Other Liabilities, as of Sep 2025, the value is 162.00 Cr.. The value appears to be improving (decreasing). It has decreased from 185.00 Cr. (Mar 2025) to 162.00 Cr., marking a decrease of 23.00 Cr..
• For Total Liabilities, as of Sep 2025, the value is 1,943.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,855.00 Cr. (Mar 2025) to 1,943.00 Cr., marking an increase of 88.00 Cr..
• For Fixed Assets, as of Sep 2025, the value is 522.00 Cr.. The value appears strong and on an upward trend. It has increased from 414.00 Cr. (Mar 2025) to 522.00 Cr., marking an increase of 108.00 Cr..
• For CWIP, as of Sep 2025, the value is 155.00 Cr.. The value appears strong and on an upward trend. It has increased from 80.00 Cr. (Mar 2025) to 155.00 Cr., marking an increase of 75.00 Cr..
• For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
• For Other Assets, as of Sep 2025, the value is 1,266.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,361.00 Cr. (Mar 2025) to 1,266.00 Cr., marking a decrease of 95.00 Cr..
• For Total Assets, as of Sep 2025, the value is 1,943.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,855.00 Cr. (Mar 2025) to 1,943.00 Cr., marking an increase of 88.00 Cr..

Notably, the Reserves (1,468.00 Cr.) exceed the Borrowings (300.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

After reviewing the key financial ratios for Azad Engineering Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 14.66. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 14.66, marking an increase of 3.46.
• For Diluted EPS (Rs.), as of Mar 25, the value is 14.66. This value is within the healthy range. It has increased from 11.20 (Mar 24) to 14.66, marking an increase of 3.46.
• For Cash EPS (Rs.), as of Mar 25, the value is 17.97. This value is within the healthy range. It has increased from 13.38 (Mar 24) to 17.97, marking an increase of 4.59.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 215.82. It has increased from 109.12 (Mar 24) to 215.82, marking an increase of 106.70.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 215.82. It has increased from 109.12 (Mar 24) to 215.82, marking an increase of 106.70.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 70.82. It has increased from 57.65 (Mar 24) to 70.82, marking an increase of 13.17.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 26.62. This value is within the healthy range. It has increased from 25.13 (Mar 24) to 26.62, marking an increase of 1.49.
• For PBIT / Share (Rs.), as of Mar 25, the value is 22.05. This value is within the healthy range. It has increased from 21.66 (Mar 24) to 22.05, marking an increase of 0.39.
• For PBT / Share (Rs.), as of Mar 25, the value is 19.20. This value is within the healthy range. It has increased from 13.67 (Mar 24) to 19.20, marking an increase of 5.53.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 13.40. This value is within the healthy range. It has increased from 9.91 (Mar 24) to 13.40, marking an increase of 3.49.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 13.52. This value is within the healthy range. It has increased from 9.91 (Mar 24) to 13.52, marking an increase of 3.61.
• For PBDIT Margin (%), as of Mar 25, the value is 37.58. This value is within the healthy range. It has decreased from 43.60 (Mar 24) to 37.58, marking a decrease of 6.02.
• For PBIT Margin (%), as of Mar 25, the value is 31.13. This value exceeds the healthy maximum of 20. It has decreased from 37.57 (Mar 24) to 31.13, marking a decrease of 6.44.
• For PBT Margin (%), as of Mar 25, the value is 27.11. This value is within the healthy range. It has increased from 23.70 (Mar 24) to 27.11, marking an increase of 3.41.
• For Net Profit Margin (%), as of Mar 25, the value is 18.92. This value exceeds the healthy maximum of 10. It has increased from 17.19 (Mar 24) to 18.92, marking an increase of 1.73.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.09. This value is within the healthy range. It has increased from 17.19 (Mar 24) to 19.09, marking an increase of 1.90.
• For Return on Networth / Equity (%), as of Mar 25, the value is 6.26. This value is below the healthy minimum of 15. It has decreased from 9.08 (Mar 24) to 6.26, marking a decrease of 2.82.
• For Return on Capital Employeed (%), as of Mar 25, the value is 8.73. This value is below the healthy minimum of 10. It has decreased from 18.32 (Mar 24) to 8.73, marking a decrease of 9.59.
• For Return On Assets (%), as of Mar 25, the value is 4.69. This value is below the healthy minimum of 5. It has decreased from 7.34 (Mar 24) to 4.69, marking a decrease of 2.65.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 0.2. It has increased from 0.04 (Mar 24) to 0.12, marking an increase of 0.08.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.17. This value is within the healthy range. It has increased from 0.05 (Mar 24) to 0.17, marking an increase of 0.12.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.34. It has decreased from 0.49 (Mar 24) to 0.34, marking a decrease of 0.15.
• For Current Ratio (X), as of Mar 25, the value is 5.20. This value exceeds the healthy maximum of 3. It has increased from 4.29 (Mar 24) to 5.20, marking an increase of 0.91.
• For Quick Ratio (X), as of Mar 25, the value is 4.38. This value exceeds the healthy maximum of 2. It has increased from 2.94 (Mar 24) to 4.38, marking an increase of 1.44.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.84. This value is below the healthy minimum of 4. It has increased from 0.60 (Mar 24) to 2.84, marking an increase of 2.24.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 14.09 (Mar 24) to 0.00, marking a decrease of 14.09.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 10.43 (Mar 24) to 0.00, marking a decrease of 10.43.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 85.91 (Mar 24) to 0.00, marking a decrease of 85.91.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 89.57 (Mar 24) to 0.00, marking a decrease of 89.57.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 9.35. This value is within the healthy range. It has increased from 3.14 (Mar 24) to 9.35, marking an increase of 6.21.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 5.71. This value is within the healthy range. It has increased from 2.24 (Mar 24) to 5.71, marking an increase of 3.47.
• For Enterprise Value (Cr.), as of Mar 25, the value is 8,332.22. It has increased from 8,045.07 (Mar 24) to 8,332.22, marking an increase of 287.15.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 18.22. This value exceeds the healthy maximum of 3. It has decreased from 23.61 (Mar 24) to 18.22, marking a decrease of 5.39.
• For EV / EBITDA (X), as of Mar 25, the value is 48.47. This value exceeds the healthy maximum of 15. It has decreased from 54.15 (Mar 24) to 48.47, marking a decrease of 5.68.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 19.21. This value exceeds the healthy maximum of 3. It has decreased from 23.67 (Mar 24) to 19.21, marking a decrease of 4.46.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 85.90 (Mar 24) to 0.00, marking a decrease of 85.90.
• For Price / BV (X), as of Mar 25, the value is 6.30. This value exceeds the healthy maximum of 3. It has decreased from 12.51 (Mar 24) to 6.30, marking a decrease of 6.21.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 19.21. This value exceeds the healthy maximum of 3. It has decreased from 23.67 (Mar 24) to 19.21, marking a decrease of 4.46.
• For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

About the Company - Qualitative Analysis